期刊
MOLECULAR ONCOLOGY
卷 6, 期 2, 页码 237-241出版社
WILEY
DOI: 10.1016/j.molonc.2012.03.001
关键词
Granulocyte colony stimulating factors (GCSF); Pegfilgastrim; Erythropoietin stimulating agents (ESAs)
类别
A common side effect of cancer treatment is bone marrow suppression. The resulting myelosuppression and anemia can cause significant morbidity and mortality for patients. Agents such as granulocyte colony stimulating factors (GCSE) and erythropoietin stimulating agents (ESAs) may be helpful to ameliorate this depression of blood counts; however these agents have risks which also need to be carefully weighed. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据